Media Contact
The statewide rollout of Digital Haematology Morphology technology is nearing completion and marks a significant milestone in the modernisation of laboratory services across NSW Health Pathology.
This technology is modernising blood film analysis across metropolitan, regional and rural laboratories for conditions like leukaemia and other blood cancers, reducing turnaround times and improving patient safety.
Project Manager Mandy Hubbard said this program is transforming how blood films are reviewed and how quickly patients receive care.
“The initiative has successfully introduced digital morphology capabilities at scale, enabling laboratory teams to access cases remotely, collaborate more effectively and reduce reliance on physical slide handling. This is particularly beneficial for regional and smaller laboratories, where access to specialist expertise can now be achieved more efficiently,” Mandy said.
“Since its commencement in April 2025, the program has expanded to 41 sites, including nine reporting-only locations.
“To support this rollout, 33 analysers have been installed and more than 200 staff trained in the new systems.”
The first sites, Tamworth and Port Macquarie, went live in February 2026, and the final site, Bankstown, was completed in mid-August 2026.

The impact of digital morphology is already evident, with up to a 15 hour improvement in turnaround times at some sites measurable improvements in turnaround times recorded across multiple sites in NSW.
Supporting staff through change
Feedback from laboratory staff highlights a strong shift from initial hesitation to confidently adopting the new technology.
“I will be honest and say that I was hesitant when we were all talking about it for the last couple of years. But now that we have gone live, I am loving it… Morphology and Micro would always be the last bastions for automation, but here we are!” – Lynda, Tamworth Laboratory, Hospital Scientist.
“Once you get the hang of it, it’s really easy to use and quicker.” – Suzanne, Wagga Wagga, Senior Scientist.
“It confirmed a previously undiagnosed case of G6PD deficiency and ensured a patient with acute leukaemia was diagnosed and transferred to a Sydney hospital the same day for treatment,” - Alison, Kempsey Lab Manager.
These experiences reflect broader feedback across sites, where staff are reporting improved efficiency, easier access to cases and reduced time spent manually locating slides.
Congratulations to everyone who has been involved. This milestone sets a strong foundation for continued innovation, delivering faster, more consistent and more connected pathology services for communities across NSW, and delivering care closer to home, especially for regional and remote patients.
